This section explains how chronic lymphocytic leukaemia (CLL) is diagnosed. CLL affects the white blood cells called lymphocytes.
Many people feel shocked and upset when told they have CLL. If you need support, call Cancer Council 13 11 20.
Learn more about:
Monoclonal B-cell lymphocytosis (MBL)
Monoclonal B-cell lymphocytosis (MBL) is a condition that causes an increased number of abnormal B-cells (a type of lymphocyte). This number is not high enough to be considered CLL. MBL is not cancer.
You don’t need treatment for MBL, but you will need regular blood tests to monitor your lymphocyte count. A small number of people with MBL develop CLL, which may eventually require treatment.
→ READ MORE: Tests for chronic lymphocytic leukaemia (CLL)
Podcast: Tests and Cancer
Listen to more of our podcast for people affected by cancer
Key resource
Download a PDF booklet on this topic.
Dr Chun Kei Kris Ma, Clinical Haematologist, Western Sydney Local Health District (clinical update); Delphine Eggen, Consumer; Dr Robin Gasiorowski, Staff Specialist, Haematology, Concord Hospital; Karl A Jobburn, Haematology Clinical Nurse Consultant, Liverpool Hospital; Yvonne King, 13 11 20 Consultant, Cancer Council NSW; Heather Mackay, Clinical Nurse Consultant, Westmead Hospital; Jennifer Paton, Consumer.
View the Cancer Council NSW editorial policy.
